BF-49-KQ10_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (2S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide, Selective PI3Kalpha inhibitor targeting PIK3CA (Novartis, 71682651)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/71682651
Similar Terms
Downloads & Tools

Genes

17 genes differentially expressed following the BF-49-KQ10_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
BUD31 BUD31 homolog (S. cerevisiae) 0.545983
LTA lymphotoxin alpha 0.535767
UBC ubiquitin C 0.507862
BEST4 bestrophin 4 0.356237
RPL37A ribosomal protein L37a 0.318598
SLC6A3 solute carrier family 6 (neurotransmitter transporter), member 3 0.290578
NAIP NLR family, apoptosis inhibitory protein 0.289667
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.249539
CAMKV CaM kinase-like vesicle-associated 0.216637

decreased expression

Symbol Name Standardized Value
CISD1 CDGSH iron sulfur domain 1 -0.930739
PSME4 proteasome (prosome, macropain) activator subunit 4 -0.568628
ANAPC11 anaphase promoting complex subunit 11 -0.324077
AP4M1 adaptor-related protein complex 4, mu 1 subunit -0.316335
MSRB2 methionine sulfoxide reductase B2 -0.302832
GPR75-ASB3 GPR75-ASB3 readthrough -0.294293
COX6A1 cytochrome c oxidase subunit VIa polypeptide 1 -0.293958
WIPI2 WD repeat domain, phosphoinositide interacting 2 -0.228293